This report contains market size and forecasts of Circulating Tumor Cell (CTC) Diagnostics in Global, including the following market information:
Global Circulating Tumor Cell (CTC) Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Circulating Tumor Cell (CTC) Diagnostics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Circulating Tumor Cell (CTC) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Circulating Tumor Cell (CTC) Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Circulating Tumor Cell (CTC) Diagnostics Market Segment Percentages, By Type, 2020 (%)
CTC Enrichment
CTC Detection
China Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Circulating Tumor Cell (CTC) Diagnostics Market Segment Percentages, By Application, 2020 (%)
Hospitals and clinics
Pharmaceuticals and biotechnology companies
Academic research institutes
CROs
Global Circulating Tumor Cell (CTC) Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Circulating Tumor Cell (CTC) Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Circulating Tumor Cell (CTC) Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Circulating Tumor Cell (CTC) Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
ApoCell, Inc.(US)
Biocep Ltd. (Israel)
Biocept, Inc.(US)
Biofluidica MicrotechnologiesLLc(US)
Celltraffix Inc.(US)
ClearbridgeBiomedics(Singapore)
Creatv Microtech, Inc.(US)
CynvenioBiosystems, Inc.(US)
EpicBiosciencesInc.(US)
FluxionBiosciences, Inc.(US)
Ikonisys, Inc.(US)
IVDiagnostics, Inc.(US)
JanssenDiagnosticsLLc(US)
QIAGEnHannoverGmbH (Germany)
RARECELLsSAs(Italy)
ScreenCell(France)
STEMCELlTechnologies, Inc.(Canada)
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Circulating Tumor Cell (CTC) Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Circulating Tumor Cell (CTC) Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Circulating Tumor Cell (CTC) Diagnostics Overall Market Size
2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size: 2021 VS 2027
2.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Circulating Tumor Cell (CTC) Diagnostics Players in Global Market
3.2 Top Global Circulating Tumor Cell (CTC) Diagnostics Companies Ranked by Revenue
3.3 Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Circulating Tumor Cell (CTC) Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Circulating Tumor Cell (CTC) Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Circulating Tumor Cell (CTC) Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Circulating Tumor Cell (CTC) Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Circulating Tumor Cell (CTC) Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Circulating Tumor Cell (CTC) Diagnostics Market Size Markets, 2021 & 2027
4.1.2 CTC Enrichment
4.1.3 CTC Detection
4.2 By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2016-2021
4.2.2 By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2022-2027
4.2.3 By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Market Size, 2021 & 2027
5.1.2 Hospitals and clinics
5.1.3 Pharmaceuticals and biotechnology companies
5.1.4 Academic research institutes
5.1.5 CROs
5.2 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2016-2021
5.2.2 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2022-2027
5.2.3 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2016-2021
6.2.2 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2022-2027
6.2.3 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Circulating Tumor Cell (CTC) Diagnostics Revenue, 2016-2027
6.3.2 US Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.3.3 Canada Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.3.4 Mexico Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Circulating Tumor Cell (CTC) Diagnostics Revenue, 2016-2027
6.4.2 Germany Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.4.3 France Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.4.4 U.K. Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.4.5 Italy Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.4.6 Russia Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.4.7 Nordic Countries Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.4.8 Benelux Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Circulating Tumor Cell (CTC) Diagnostics Revenue, 2016-2027
6.5.2 China Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.5.3 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.5.4 South Korea Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.5.5 Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.5.6 India Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Circulating Tumor Cell (CTC) Diagnostics Revenue, 2016-2027
6.6.2 Brazil Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.6.3 Argentina Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue, 2016-2027
6.7.2 Turkey Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.7.3 Israel Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.7.4 Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
6.7.5 UAE Circulating Tumor Cell (CTC) Diagnostics Market Size, 2016-2027
7 Players Profiles
7.1 ApoCell, Inc.(US)
7.1.1 ApoCell, Inc.(US) Corporate Summary
7.1.2 ApoCell, Inc.(US) Business Overview
7.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.1.4 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.1.5 ApoCell, Inc.(US) Key News
7.2 Biocep Ltd. (Israel)
7.2.1 Biocep Ltd. (Israel) Corporate Summary
7.2.2 Biocep Ltd. (Israel) Business Overview
7.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.2.4 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.2.5 Biocep Ltd. (Israel) Key News
7.3 Biocept, Inc.(US)
7.3.1 Biocept, Inc.(US) Corporate Summary
7.3.2 Biocept, Inc.(US) Business Overview
7.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.3.4 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.3.5 Biocept, Inc.(US) Key News
7.4 Biofluidica MicrotechnologiesLLc(US)
7.4.1 Biofluidica MicrotechnologiesLLc(US) Corporate Summary
7.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview
7.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.4.4 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.4.5 Biofluidica MicrotechnologiesLLc(US) Key News
7.5 Celltraffix Inc.(US)
7.5.1 Celltraffix Inc.(US) Corporate Summary
7.5.2 Celltraffix Inc.(US) Business Overview
7.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.5.4 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.5.5 Celltraffix Inc.(US) Key News
7.6 ClearbridgeBiomedics(Singapore)
7.6.1 ClearbridgeBiomedics(Singapore) Corporate Summary
7.6.2 ClearbridgeBiomedics(Singapore) Business Overview
7.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.6.4 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.6.5 ClearbridgeBiomedics(Singapore) Key News
7.7 Creatv Microtech, Inc.(US)
7.7.1 Creatv Microtech, Inc.(US) Corporate Summary
7.7.2 Creatv Microtech, Inc.(US) Business Overview
7.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.4.4 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.7.5 Creatv Microtech, Inc.(US) Key News
7.8 CynvenioBiosystems, Inc.(US)
7.8.1 CynvenioBiosystems, Inc.(US) Corporate Summary
7.8.2 CynvenioBiosystems, Inc.(US) Business Overview
7.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.8.4 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.8.5 CynvenioBiosystems, Inc.(US) Key News
7.9 EpicBiosciencesInc.(US)
7.9.1 EpicBiosciencesInc.(US) Corporate Summary
7.9.2 EpicBiosciencesInc.(US) Business Overview
7.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.9.4 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.9.5 EpicBiosciencesInc.(US) Key News
7.10 FluxionBiosciences, Inc.(US)
7.10.1 FluxionBiosciences, Inc.(US) Corporate Summary
7.10.2 FluxionBiosciences, Inc.(US) Business Overview
7.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.10.4 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.10.5 FluxionBiosciences, Inc.(US) Key News
7.11 Ikonisys, Inc.(US)
7.11.1 Ikonisys, Inc.(US) Corporate Summary
7.11.2 Ikonisys, Inc.(US) Business Overview
7.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.11.4 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.11.5 Ikonisys, Inc.(US) Key News
7.12 IVDiagnostics, Inc.(US)
7.12.1 IVDiagnostics, Inc.(US) Corporate Summary
7.12.2 IVDiagnostics, Inc.(US) Business Overview
7.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.12.4 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.12.5 IVDiagnostics, Inc.(US) Key News
7.13 JanssenDiagnosticsLLc(US)
7.13.1 JanssenDiagnosticsLLc(US) Corporate Summary
7.13.2 JanssenDiagnosticsLLc(US) Business Overview
7.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.13.4 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.13.5 JanssenDiagnosticsLLc(US) Key News
7.14 QIAGEnHannoverGmbH (Germany)
7.14.1 QIAGEnHannoverGmbH (Germany) Corporate Summary
7.14.2 QIAGEnHannoverGmbH (Germany) Business Overview
7.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.14.4 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.14.5 QIAGEnHannoverGmbH (Germany) Key News
7.15 RARECELLsSAs(Italy)
7.15.1 RARECELLsSAs(Italy) Corporate Summary
7.15.2 RARECELLsSAs(Italy) Business Overview
7.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.15.4 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.15.5 RARECELLsSAs(Italy) Key News
7.16 ScreenCell(France)
7.16.1 ScreenCell(France) Corporate Summary
7.16.2 ScreenCell(France) Business Overview
7.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.16.4 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.16.5 ScreenCell(France) Key News
7.17 STEMCELlTechnologies, Inc.(Canada)
7.17.1 STEMCELlTechnologies, Inc.(Canada) Corporate Summary
7.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview
7.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.17.4 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (2016-2021)
7.17.5 STEMCELlTechnologies, Inc.(Canada) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Circulating Tumor Cell (CTC) Diagnostics Market Opportunities & Trends in Global Market
Table 2. Circulating Tumor Cell (CTC) Diagnostics Market Drivers in Global Market
Table 3. Circulating Tumor Cell (CTC) Diagnostics Market Restraints in Global Market
Table 4. Key Players of Circulating Tumor Cell (CTC) Diagnostics in Global Market
Table 5. Top Circulating Tumor Cell (CTC) Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Circulating Tumor Cell (CTC) Diagnostics Product Type
Table 9. List of Global Tier 1 Circulating Tumor Cell (CTC) Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Circulating Tumor Cell (CTC) Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. ApoCell, Inc.(US) Corporate Summary
Table 31. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 32. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. Biocep Ltd. (Israel) Corporate Summary
Table 34. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 35. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. Biocept, Inc.(US) Corporate Summary
Table 37. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 38. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. Biofluidica MicrotechnologiesLLc(US) Corporate Summary
Table 40. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 41. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. Celltraffix Inc.(US) Corporate Summary
Table 43. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 44. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. ClearbridgeBiomedics(Singapore) Corporate Summary
Table 46. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 47. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 48. Creatv Microtech, Inc.(US) Corporate Summary
Table 49. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 50. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 51. CynvenioBiosystems, Inc.(US) Corporate Summary
Table 52. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 53. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 54. EpicBiosciencesInc.(US) Corporate Summary
Table 55. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 56. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 57. FluxionBiosciences, Inc.(US) Corporate Summary
Table 58. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 59. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 60. Ikonisys, Inc.(US) Corporate Summary
Table 61. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 62. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 63. IVDiagnostics, Inc.(US) Corporate Summary
Table 64. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 65. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 66. JanssenDiagnosticsLLc(US) Corporate Summary
Table 67. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 68. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 69. QIAGEnHannoverGmbH (Germany) Corporate Summary
Table 70. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 71. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 72. RARECELLsSAs(Italy) Corporate Summary
Table 73. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 74. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 75. ScreenCell(France) Corporate Summary
Table 76. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 77. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 78. STEMCELlTechnologies, Inc.(Canada) Corporate Summary
Table 79. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 80. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Circulating Tumor Cell (CTC) Diagnostics Segment by Type
Figure 2. Circulating Tumor Cell (CTC) Diagnostics Segment by Application
Figure 3. Global Circulating Tumor Cell (CTC) Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Circulating Tumor Cell (CTC) Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2020
Figure 8. By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
Figure 12. US Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
Figure 24. China Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
ApoCell, Inc.(US)
Biocep Ltd. (Israel)
Biocept, Inc.(US)
Biofluidica MicrotechnologiesLLc(US)
Celltraffix Inc.(US)
ClearbridgeBiomedics(Singapore)
Creatv Microtech, Inc.(US)
CynvenioBiosystems, Inc.(US)
EpicBiosciencesInc.(US)
FluxionBiosciences, Inc.(US)
Ikonisys, Inc.(US)
IVDiagnostics, Inc.(US)
JanssenDiagnosticsLLc(US)
QIAGEnHannoverGmbH (Germany)
RARECELLsSAs(Italy)
ScreenCell(France)
STEMCELlTechnologies, Inc.(Canada)